Has Mark Kipnes received payments from drug or device companies?

Yes. Drug and device makers reported $10,283,027 in general payments to Mark Kipnes across 2,541 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Kipnes did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Kipnes come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Kipnes

Endocrinology, Diabetes & Metabolism · San Antonio, TXNPI 1376501965

Payments from drug & device makers

$10,283,027in general payments, 2019–2025

Across 2,541 payments — averaging $4046.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$3.2M
Medtronic$2.1M
Dexcom, Inc.$1.9M
AbbVie$1.3M
Insulet Corporation$606K
Boehringer Ingelheim$319K
plus $782K from 54 others

$11,624in research payments, 2019–2025

Across 22 payments — averaging $528.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$7K
AbbVie$3K
Corcept Therapeutics$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	616	$3,237,569
Medtronic(2 entities)	230	$2,098,862
Dexcom, Inc.	74	$1,900,864
AbbVie(2 entities)	149	$1,338,711
Insulet Corporation	86	$605,903
Boehringer Ingelheim	96	$319,497
Pfizer	63	$270,074
Mannkind Corporation	84	$114,734
Eli Lilly	8	$89,817
Vertex	2	$85,076
Amgen(2 entities)	71	$76,445
Novo Nordisk AS	43	$47,138
Boehringer Ingelheim International GmbH	127	$27,449
Ionis Pharmaceuticals, Inc.	6	$18,320
AstraZeneca	104	$16,889
Senseonics, Incorporated	3	$9,312
Gilead	7	$4,064
Novo Nordisk	143	$3,649
Shionogi Inc	3	$3,450
Ascendis Pharma Endocrinology Inc	1	$3,000
Lilly USA, LLC	95	$1,459
Radius Health, Inc.	57	$1,275
Tandem Diabetes Care, Inc.	7	$927
Ascensia Diabetes Care US Inc.	15	$786
Xeris Pharmaceuticals, Inc.	40	$749
Corcept Therapeutics	29	$736
Sanofi-aventis U.S. LLC	44	$707
Amarin Pharma, Inc.	35	$624
Antares Pharma, Inc.	69	$590
Recordati_rare_diseases_inc.	15	$405
Novartis	21	$401
Merck	30	$357
BETA Bionics, Inc.	5	$316
Zealand Pharma US, Inc.	17	$299
Sequel Med Tech, LLC	31	$296
Valeritas, Inc.	10	$283
Esperion Therapeutics, Inc.	18	$273
Cequr Corporation	3	$223
Bayer	14	$222
BD	10	$194
Ultragenyx Pharmaceutical Inc.	7	$137
Nalpropion Pharmaceuticals LLC	6	$89
Johnson & Johnson	4	$74
EUSA Pharma (US) LLC	2	$58
OPKO Pharmaceuticals, LLC	4	$56
Ipsen Biopharmaceuticals, Inc	3	$54
Soleno Therapeutics, Inc.	2	$54
Kyowa Kirin, Inc.	2	$54
Shire North American Group Inc	2	$53
Lifescan, Inc.	3	$51
Neurocrine Biosciences, Inc.	2	$48
Currax Pharmaceuticals LLC	3	$43
Tolmar, Inc.	3	$42
IBSA Pharma Inc.	2	$38
Companion Medical, Inc.	2	$27
Organogenesis Inc.	2	$24
Roche Diabetes Care, Inc.	2	$24
Almatica Pharma LLC	1	$22
Halozyme Inc	1	$21
Madrigal Pharmaceuticals	1	$19

How this compares

$10,283,027 in reported general payments places this provider in the 95th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

See all endocrinology, diabetes & metabolism providers in Texas →

Other endocrinology, diabetes & metabolism in San Antonio

Ralph DefronzoSan Antonio$4.8M
Eugenio CersosimoSan Antonio$4M
Devjit TripathySan Antonio$1.5M
Carolina Solis-HerreraSan Antonio$1.3M
Firas AkhrassSan Antonio$900K
Julio RosenstockDallas$24.9M
Michelle WelchShavano Park$17.3M
Maria CabanillasHouston$16.4M
Sumana GangiMesquite$13.2M
Damaris VegaHouston$12.3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →